Skip to content
StockMarketAgent
Direct answer
WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $56.3, high $78.6, with mid-point at $65.8.
Stock analysis

WELL Welltower Inc. fair value $66–$79

WELL
By StockMarketAgent.AI team· supervised by
Analysé: 2026-05-09Prochaine mise à jour: 2026-08-09Methodology v2.4Archetype: REITNYSE · Real Estate
View archive
Cours
$214.63
▼ -148.84 (-69.35%)
Juste valeur
$66
$66–$79
Notation
Vendre
confidence 88/100
Potentiel de hausse
-69.3%
upside to fair value
Marge de sécurité
$55.92
buy below · 15%
Capitalisation boursière
$151.5B
P/E fwd 64.5
Repli en anglaisFR
Affichage de la source anglaise pendant la traduction
Ce rapport n'a pas encore été traduit. Actualisez dans quelques minutes une fois que la file d'attente de traduction aura rattrapé son retard.

§1 Résumé

  • Composite fair value $66 with high case $79.
  • Implied downside of 69.3% to fair value.
  • Moat 6.5/10 · confidence 88/100 · REIT.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$66
Margin of safety
-226.2%
Confidence
88/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$214.63Price
FV $65.79
High $78.60

WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Unmatched real estate portfolio in
    Unmatched real estate portfolio in highly attractive, high-barrier micro-markets.
  • Data Science platform enabling highly
    Data Science platform enabling highly disciplined capital allocation.
  • Cycle upside
    Unprecedented demand driven by the aging 'silver tsunami' outstripping new senior housing supply.

§2 Cas baissier

A sustained high-interest-rate environment coupled with sticky healthcare labor inflation would severely constrain accretive acquisitions while crushing property-level operating margins, driving valuation sharply toward the $56.34 low.

Comment cette thèse peut échouer

Cost of Capital Blowout

· Medium

Prolonged high interest rates severely limit accretive acquisition volume and compress real estate cap rates across the sector.

FV impact
Severe downside to $56.34
Trigger
12-24 months

Structural Labor Squeeze

· Medium

Persistent shortages in healthcare staffing drive runaway wage inflation, permanently squeezing operator margins and reducing AFFO generation.

FV impact
Moderate downside
Trigger
24-36 months

Demographic Supply Glut

· Low

Competitors massively overbuild in key micro-markets ahead of the aging wave, crushing occupancy and pricing power.

FV impact
Minor downside
Trigger
3-5 years
Signaux d'alerte précoce à surveiller
MétriqueActuelSeuil de déclenchement
Decelerating or negative sequential AFFO per share growth.MonitorDeterioration versus the report thesis
Stalling occupancy rate recovery across the core premium senior housing portfolio.MonitorDeterioration versus the report thesis
Narrowing investment spreads between implied cap rates and marginal cost of debt.MonitorDeterioration versus the report thesis
Surging operator labor costs per occupied unit compressing site-level EBITDAR.MonitorDeterioration versus the report thesis
Multiple expansion on recently closed asset sales indicating market exhaustion.MonitorDeterioration versus the report thesis

§3 Historique financier

Compte de résultat — six derniers exercices
PosteT−0T−1T−2T−3TCAC
Période2022-12-312023-12-312024-12-312025-12-31Trend
Chiffre d'affaires$5.78B$6.48B$7.85B$10.67B+22.7%
Marge brute$2.22B$2.53B$3.02B$4.18B+23.5%
Résultat d'exploitation$746.2M$940.5M$1.15B$355.2M-21.9%
Résultat net$141.2M$340.1M$951.7M$936.8M+87.9%
BPA (dilué)$0.30$0.66$1.57$1.39+66.7%
EBITDA$2.04B$2.40B$2.78B$2.31B+4.2%
R&D
SG&A$150.4M$179.1M$235.5M$1.75B+126.5%

Scores de qualité

Piotroski F-score
7 / 9
Composite qualité 0–9
Altman Z-score
3.89
Risque de faillite (>3 sûr)
Beneish M-score
-3.02
Risque de manipulation des résultats
OCF / Résultat net
3.08×
>1 indique une qualité élevée des résultats
Seuil de qualité comptable
Pass
Seuil ajusté au secteur
ROIC
0.2%
Rendement du capital investi
§3

Numbers analysis

Allocation du capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Abonnés individuels — à partir de §411 sections supplémentaires

Lire l'analyse complète — 11 sections supplémentaires.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Rapport complet pour chaque action couverte
24 mois d'archives de notations
Briefings de liste de suivi + alertes de changement de notation
Export PDF + DOCX dans n'importe quelle langue
Démarrer l'essai gratuit
Annulable à tout moment.
FAQ

WELL — frequently asked questions

  1. Based on our latest independent analysis, WELL looks meaningfully overvalued. The current price is $215 versus a composite fair-value midpoint of $65.8 (range $56.3–$78.6), which implies roughly 69.3% downside to the midpoint.
Related coverage

Names readers of WELL also follow

Same archetype: reit